Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classical pathway complement activation in association with paraproteinaemia

P F Naish, C Collins, J Barratt

    Immunology
    |October 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fungal Planet description sheets: 1781-1866.

    Persoonia·2025
    Same author

    In situ formation of micro/nano phase composite for 3D printing clinically relevant bioresorbable stents.

    Materials today. Chemistry·2025
    Same author

    Features and frequency of use of electronic health records in primary care across 20 countries: a cross-sectional study.

    Public health·2024
    Same author

    Extending Pharmacy Services to the Point of Discharge.

    Irish medical journal·2023
    Same author

    Pedi-R-MAPP | the development, testing, validation, and refinement of a digital nutrition awareness tool.

    Clinical nutrition (Edinburgh, Scotland)·2023
    Same author

    Recurrent Lung Injury Resulting From Unusual Cases of Aero-Digestive Disease.

    Dysphagia·2023
    Same journal

    Epidermal Dominance of Metabolically Constrained Immune Niches Underpins Immune Activation Signatures and Clinical Severity in Psoriatic Disease.

    Immunology·2026
    Same journal

    Thymic APC Networks Orchestrate T-Cell Selection: Mechanisms and Therapeutic Opportunities in Immune Disorders.

    Immunology·2026
    Same journal

    Immune Checkpoints in Leukaemia as Gatekeepers of Immuno-Modulation.

    Immunology·2026
    Same journal

    Senescent Human Liver Endothelial Cells Mediate CD4<sup>+</sup> T Cell Recruitment via ICOSL.

    Immunology·2026
    Same journal

    The Transcription Factor EGR2 Plays a Central Role in the Expansion and Function of TCRαβ<sup>+</sup>CD4<sup>-</sup>CD8<sup>-</sup> Double Negative T Cells in lpr Lupus Mice.

    Immunology·2026
    Same journal

    Epigenetic Gene Networks Governing Immune State Transitions Across the Lifespan.

    Immunology·2026
    See all related articles

    Five patients with paraproteinaemia showed complement activation, with cryoglobulinaemia or immunoglobulin aggregation causing low complement levels. Other patients had isolated low C1q or C3, with no clear clinical link.

    Area of Science:

    • Immunology
    • Clinical Medicine
    • Biochemistry

    Background:

    • Paraproteinaemia, characterized by abnormal proteins in the blood, can be associated with immune system dysregulation.
    • The complement system, a crucial part of innate immunity, plays a vital role in host defense and inflammation.
    • Alterations in complement levels, such as hypocomplementaemia, may indicate underlying pathological processes.

    Purpose of the Study:

    • To investigate the prevalence and mechanisms of complement activation in patients with paraproteinaemia.
    • To identify potential associations between paraproteinaemia, complement abnormalities, and clinical findings.

    Main Methods:

    • Analysis of complement pathway activation in a cohort of 23 patients with paraproteinaemia.
    • Assessment of complement component levels (C1q, C3) and identification of associated factors like cryoglobulinaemia and immunoglobulin aggregation.

    Related Experiment Videos

    Main Results:

    • Five out of 23 patients exhibited significant classical pathway complement activation.
    • Mechanisms included cryoglobulinaemia in one patient and in vivo immunoglobulin aggregation in four.
    • Three patients had isolated low C1q, and three had isolated low C3, without other complement abnormalities.
    • No specific IgG subclass or clinical abnormality was consistently associated with hypocomplementaemia.

    Conclusions:

    • Paraproteinaemia can lead to complement activation and hypocomplementaemia through various mechanisms.
    • Isolated deficiencies in complement components (C1q, C3) can occur in paraproteinaemia patients.
    • Further research is needed to elucidate the clinical significance and precise mechanisms linking paraproteinaemia to complement abnormalities.